Search

Search Constraints

You searched for: Author/Creator Forsterova, Kristina

Search Results

1. A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma. (30th August 2020)

2. Alternating R‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma. Issue 1 (30th October 2017)

3. Mantle cell lymphoma‐variant Richter syndrome: Detailed molecular‐cytogenetic and backtracking analysis reveals slow evolution of a pre‐MCL clone in parallel with CLL over several years. Issue 10 (2nd August 2016)

4. Micafungin as empirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics. Issue 5 (May 2013)

5. Potential loss of prognostic significance of minimal residual disease assessment after R‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance. Issue 5 (13th September 2018)

6. Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation. Issue 2 (13th December 2018)

7. The use of formalin‐fixed, paraffin‐embedded lymph node samples for the detection of minimal residual disease in mantle cell lymphoma. (14th October 2014)